Patents
Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
10/2007
10/03/2007EP1838296A2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
10/03/2007CN101045707A Method for synthesising 1-amino-isoquinoline
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007US7276607 5-HT7 receptor antagonists
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/27/2007WO2007109201A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/27/2007WO2007109192A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/27/2007WO2007109172A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/27/2007WO2007109160A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/27/2007WO2007109154A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/27/2007WO2007107373A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
09/27/2007WO2007107352A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
09/27/2007WO2007107245A1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them
09/27/2007US20070225372 Amides as Bace Inhibitors
09/27/2007US20070225365 Cetp Inhibitors
09/27/2007US20070225327 3-Methyl-2-[4'-(pyridin-3-ylmethoxymethyl)-biphenyl-4-sulfonylamino]-butyric acid; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/27/2007US20070225324 e.g. N-[2-(2-Hydroxy-ethyl)-1-oxo-1,2-dihydro-isoquinolin-5-yl]-benzamide; antiinflammatory and analgesic agent; rheumatoid arthritis, osteoarthritis, Parkinson's disease, uveitis, asthma, cardiovascular conditions, myocardial infarction
09/27/2007US20070225232 Tetrahydro-Imidazo [1,5-A] Pyridyin Derivatives as Aldosterone Synthase Inhibitors
09/27/2007US20070224447 Organometallic Complex, Luminescent Solid, Organic el Element and Organic el Display
09/27/2007US20070224130 Tetrahydro-Naphthalene Derivatives as Glucocorticoid Receptor Modulators
09/27/2007DE102006012544A1 Substituierte 1-Amino 4-phenyl-dihydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 1-amino 4-phenyl-dihydroisoquinolines, processes for their preparation, their use as a medicament, and medicament containing them
09/27/2007CA2647024A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
09/27/2007CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
09/27/2007CA2646227A1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them
09/27/2007CA2645556A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/27/2007CA2645551A1 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
09/26/2007EP1837332A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
09/26/2007CN100339375C Metabolites of ecteinascidin 743
09/25/2007US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/20/2007WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
09/20/2007WO2007104680A1 Polymerisation of ethylene and alpha-olefins with imino-quinolinol complexes
09/20/2007WO2007104582A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
09/20/2007CA2647031A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
09/20/2007CA2637597A1 Tetrahydronaphthalene derivatives, processes for preparing them and their use as anti-inflammatory agents
09/19/2007EP1834948A1 Tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiinflammatory drugs
09/19/2007EP1833803A2 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof
09/19/2007EP1833797A1 Azacyclic compounds as inhbitors of sensory neurone specific channels (sns)
09/19/2007CN101039914A Trifluoromethyl substituted benzamide as kinase inhibitors
09/19/2007CN101039662A Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof
09/19/2007CN101037411A Splitting method of tetrahydroisoquinoline racemes
09/19/2007CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
09/18/2007US7271270 High affinity small molecule C5a receptor modulators
09/18/2007CA2220533C 3-amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
09/18/2007CA2095797C Arylacetamides
09/13/2007WO2007103996A1 2-(aryloxy)acetamide factor viia inhibitors useful as anticoagulants
09/13/2007US20070213364 Alkoxyphenylpropanoic Acid Derivatives
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
09/13/2007US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/12/2007EP1832579A1 Polymerisation of ethylene and alpha-olefins with imino-quinolinol complexes
09/12/2007EP1831174A1 Amide derivatives
09/12/2007EP1831173A1 Tetrahydroisoquinoline compounds for treatment of cns disorders
09/12/2007EP1831157A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase
09/12/2007CN101035764A 4-trifluoromethoxyphenoxybenzol-4-sulfonic acids, method for the production and use thereof in medicaments
09/11/2007US7268232 Androgen receptor modulators and method of treating disease using the same
09/11/2007US7268147 For therapy of inflammatory, allergic and respiratory diseases
09/11/2007US7268142 4-chloro-N-[2-(6,7-dimethoxy-quinazolin-4-yl)-1,2,3,4-tetrahydro-isoquinolin-7-yl]-benzenesulfonamide; schizophrenia, central nervous system disorders
09/11/2007US7268135 Biaryl sulfonamides and methods for using same
09/11/2007CA2254066C Compounds with anti-inflammatory and immunosuppressive activities
09/07/2007WO2007098608A1 Chiral ligands, their preparation and uses thereof in assymetric reactions
09/06/2007US20070208166 Tao Kinase Modulators And Method Of Use
09/05/2007EP1829864A1 Isoquinoline derivatives as calpain inhibitors
09/05/2007EP1828138A1 Dpp-iv inhibitors
09/05/2007EP1827435A2 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN101029025A Method for generating (3S,4aS,8aS)-decahydroquinoline-3-carboxylic tert-butyl amine catalyzed and hydrogenated by (S)-tetrahydrosquinoline-3-carboxylic tert-butyl amine
09/04/2007US7265131 For therapy of disease-states associated with nuclear receptor activity
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265116 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease
08/2007
08/30/2007US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol
08/30/2007US20070203179 Azadecalin Glucocorticoid Receptor Modulators
08/30/2007US20070203118 Substituted tetrahydroisoquinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drugs
08/29/2007EP1824883A2 Saquinavir derivatives useful in immunoassay
08/29/2007CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
08/23/2007WO2007093366A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007US20070197522 Dpp-iv inhibitors
08/23/2007CA2636617A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/22/2007EP1819669A2 Novel inhibitors of histone deacetylase for the treatment of disease
08/22/2007EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors
08/22/2007EP1819337A2 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
08/22/2007CN1333621C Phenyl pyridine-iridium metal complex compounds for organic electroluminescent device, and organic electroluminescent device using the compounds
08/22/2007CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
08/22/2007CN1332939C Novel compounds inhibiting factor Xa activity
08/22/2007CN101023060A Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them
08/21/2007US7259158 Naphthaline derivatives as H3 inverse agonists
08/16/2007WO2006052555A8 Niacin receptor agonists, compositions containing such compounds and methods of treatment
08/16/2007US20070191424 such as (2R)-2-{(1S)-6,7-dimethoxy-1-[2-(4-trifluoromethyl-phenyl)-ethyl]-3,4-dihydro-1H-isoquinolin-2-yl}-N-methyl-2-phenyl-acetamide, used as orexin receptor antagonists, for preventing or treating sleep disorders
08/16/2007US20070191423 Isoquinoline derivatives
08/16/2007US20070191378 Anthranilic acid derivatives and their use as activators of the hm74a receptor
08/16/2007US20070191328 Isoquinoline compounds
08/15/2007EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds
08/15/2007CN1331862C Di-aryl acid derivatives as PPAR receptor ligands
08/14/2007US7256210 7-amido-isoindolyl compounds and methods of their use
08/14/2007US7256201 Selective estrogen receptor-β ligands
08/14/2007CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
08/09/2007WO2007090068A2 Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
08/09/2007WO2007088878A1 Method for producing benzazepinone
08/09/2007US20070185160 1-(2H)-isoquinolone derivative
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 119